Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
- Sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Study ID
- NCT07765550
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Myopia
- Pre-myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - 6 Years
- Healthy Volunteers
- Not accepted
Interventions
- Artificial Intelligence Assisted DIMS based Spectacle Lens — DEVICEThe AI-DIMS defocus spectacle frame, featuring DIMS-based lenses and an intelligent AI frame, is designed to be worn for at least 10 hours per day. The frame automatically tracks and records wearing duration parameters.
- Smartwatches — DEVICEInserted prompt system of the smartwatches can remind the users to go outside. Inserted sensors can record outdoor parameters such as outdoor time, light intensity, activity pattern, etc.
Study Details
Pre-myopia refers to a condition in which children have not yet developed myopia but exhibit insufficient hyperopic reserve (≤ +0.75 D). This is particularly relevant for young children aged 6 years and under; if their hyperopic reserve is depleted prematurely and they progress into the pre-myopia stage, the likelihood of developing myopia or even high myopia in the future becomes extremely high. Therefore, this study plans to conduct a parallel-design, open-label, single-center randomized controlled clinical trial to evaluate the efficacy and safety of artificial intelligence-assisted defocus incorporated multiple segments (DIMS) based spectacle lens in preventing and controlling myopia in pre-myopic children aged 3 to 6 years.
Key Dates
- First listed
- Aug 14, 2026
- Start date
- Sep 12, 2026
- Status verified
- Aug 2026
- Primary completion
- May 31, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 128 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Intervention groupWear AI-assisted DIMS-based spectacle lens (at least 10 hours a day), as well as smartwatches
- Other: Control groupWear smartwatches
Primary Outcome Measure
Changes in axial length [ Time Frame: From baseline to the 12-month follow-up ]
Central Contacts
- Xiangui He, Prof+86 15000755422
Related Studies
- Diagnostic Innovations in Glaucoma StudyRecruiting · University of California, San Diego · La Jolla, California
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Contoura With Phorcides Compared to Wavefront Optimized LASIKRecruiting · Daniel Terveen · Bozeman, Montana
- Efficacy of Repeated Low-level Red-light Therapy in Myopia ControlRecruiting · University of California, San Francisco · San Francisco, California